Afimoxifene New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP04749CAS No. ：68392-35-8Purity：98%

Get Quotation Now

Tel: 0086-13026320035 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	68392-35-8	Cat. No.	BCP04749
Name	Afimoxifene
Synonyms	4-Monohydroxytamoxifen;4-OHT; 4-HT; OHTAM;4-Hydroxytamoxifen;Hydroxytamoxifen;trans-4-Hydroxytamoxifen; Tamoxifen metabolite B;
SMILES	CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
Chemical Name
Formula	C26H29NO2	M. Wt	387.51
Purity	98%	Storage	Store at 4-8°C
Description	Afimoxifene (4-hydroxytamoxifen) is a selective estrogen receptor modulator which is the active metabolite of tamoxifen. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. Afimoxifene has completed a phase II clinical trial for the treatment of cyclical mastalgia. A study in France on 55 women showed that rubbing afimoxifene on the skin was as good as tamoxifen tablets at slowing breast cancer growth. A US trial will compare 6 weeks use before breast cancer surgery. Skin application can reduce systemic levels by a factor of nine and this is expected to reduce the unpleasant side-effects of tamoxifen.